The British Pharmacopoeia (BP) is a comprehensive collection of official standards for pharmaceutical and medicinal products, containing around 4,000 legally mandated standards known as monographs, in addition to supplementary Chapters and Appendices. Having provided official standards for medicines since 1864, the BP makes an important contribution to the role of the Medicines and Healthcare products Regulatory Agency (MHRA) in protecting public health by providing quality standards for pharmaceutical and medicinal products.
LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances for around 40 monographs and accompanying chemical reference standards each year; BP 2022 included a total of 53 new and 133 revised monographs.
Published annually in August, in both hardcopy and digital formats, the 6 volumes of BP continue to have a wide international reach with BP 2022 currently being used in over 100 countries.
Visit the BP website for further details.